Please use this identifier to cite or link to this item:
Title: Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.
Austin Authors: Peverelle, Matthew R ;Asadi, Khashayar ;De Cruz, Peter P 
Affiliation: Department of Anatomical Pathology, Austin Health, Heidelberg, Victoria, Australia
Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: 5-Oct-2020 2020-03-31
Publication information: Journal of Crohn's & Colitis 2020; 14(10): 1498-1499
DOI: 10.1093/ecco-jcc/jjaa062
ORCID: 0000-0003-0136-6699
Journal: Journal of Crohn's & Colitis
PubMed URL: 32232397
Type: Journal Article
Subjects: Crohn’s disease
Liver transplantation
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jan 27, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.